State of Wisconsin Investment Board’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-240,934
Closed -$6.62M 2767
2022
Q3
$6.62M Sell
240,934
-197,160
-45% -$4.89M 0.02% 788
2022
Q2
$10.1M Sell
438,094
-38,229
-8% -$893K 0.03% 633
2022
Q1
$10.4M Buy
476,323
+119,916
+34% +$2.49M 0.02% 768
2021
Q4
$7.62M Sell
356,407
-264,286
-43% -$5.54M 0.01% 888
2021
Q3
$13M Buy
620,693
+31,905
+5% +$696K 0.03% 646
2021
Q2
$13.6M Buy
588,788
+188,046
+47% +$4.33M 0.03% 622
2021
Q1
$8.86M Buy
400,742
+369,562
+1,185% +$8.55M 0.02% 793
2020
Q4
$582K Sell
31,180
-1,310
-4% -$21.5K ﹤0.01% 1483
2020
Q3
$471K Buy
32,490
+620
+2% +$7.88K ﹤0.01% 1504
2020
Q2
$357K Buy
31,870
+1,400
+5% +$15.7K ﹤0.01% 1521
2020
Q1
$304K Buy
+30,470
New +$426K ﹤0.01% 1494

Other funds holding CHNG

State of Wisconsin Investment Board's CHNG Position: Q4 2022 in Review

State of Wisconsin Investment Board sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 240,934 shares — an estimated $6.62M sold.

State of Wisconsin Investment Board first reported a position in CHNG in Q1 2020 and held it in 11 quarters. The position peaked at $13.6M in Q2 2021. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • State of Wisconsin Investment Board reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 240,934 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $6.62M.
  • State of Wisconsin Investment Board first reported a position in Change Healthcare Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • State of Wisconsin Investment Board's Change Healthcare Inc. Common Stock position peaked at $13.6M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2022, filed 14 Feb 2023.